title: Verteporfin in Photodynamic Therapy: report no. 5.
authors.forename: Francesco
authors.initials: F
authors.lastname: Bandello
authors.forename: Kevin
authors.initials: K
authors.lastname: Blinder
authors.forename: Neil M
authors.initials: NM
authors.lastname: Bressler
authors.forename: Alison L
authors.initials: AL
authors.lastname: Brown
authors.forename: Joan W
authors.initials: JW
authors.lastname: Miller
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Potter
authors.forename: Constantin
authors.initials: C
authors.lastname: Pournaras
authors.forename: Al
authors.initials: A
authors.lastname: Reaves
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Rosenfeld
authors.forename: Jason S
authors.initials: JS
authors.lastname: Slakter
authors.forename: Gisele
authors.initials: G
authors.lastname: Soubrane
authors.forename: H Andrew
authors.initials: HA
authors.lastname: Strong
authors.forename: Michael
authors.initials: M
authors.lastname: Stur
mesh_terms: D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005584:Fovea Centralis; D006801:Humans; D009216:Myopia / Q000150:complications*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077362:Verteporfin; D014792:Visual Acuity / Q000502:physiology
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin